AArkstore enterprise 7th Novenber 2014
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60326/peptic-ulcer-therapeuticspipeline-assessment-and-market-forecasts Published: Jan 2012 | No. Of Pages: 68 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
2018
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Summary the industry analysis specialist, has released its new report, “Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018�. The report is an essential source of information and analysis on the global Peptic Ulcer Therapeutics market. The report identifies the key trends shaping and driving the global Peptic Ulcer Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Peptic Ulcer Therapeutics sector. This report is built using
Website : http://www.aarkstore.com/
AArkstore enterprise data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope The report provides information on the key drivers and challenges of the Peptic Ulcer Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Peptic Ulcer Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Peptic Ulcer Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Peptic Ulcer Therapeutics market. - Analysis of key recent licensing and partnership agreements in Peptic Ulcer Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Peptic Ulcer Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Peptic Ulcer Therapeutics market in future.
Website : http://www.aarkstore.com/
AArkstore enterprise - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Peptic Ulcer Therapeutics market landscape? – Identify, understand and capitalize.
Tables Of Contents 2 Peptic Ulcer Therapeutics - Introduction 7 2.1 Disease Overview 7 2.1.1 Complications 8 2.2 Epidemiology 8 2.2.1 Prevalence/Incidence 8 2.2.2 Trends in Prevalence/Incidence 9 2.2.3 Mortality 9 2.3 Etiology and Pathophysiology 9 2.3.1 H. pylori Infection 9 2.3.2 Use of NSAIDs 10 2.3.3 Other Causes and Risk Factors 11 2.4 Signs and Symptoms 12 2.5 Diagnosis 12
Website : http://www.aarkstore.com/
AArkstore enterprise 2.5.1 Noninvasive Techniques 12 2.5.2 Invasive Techniques 13 2.6 Treatment and Management Options 13 2.6.1 Treatment of H. pylori-Induced Peptic Ulcer 13 2.6.2 Treatment of NSAID-Induced Peptic Ulcer 14 2.6.3 Treatment of Ulcer Complications 14 2.7 GlobalData Pipeline Report Guidance 15 3 Peptic Ulcer Therapeutics - Market Characterization 16 3.1 Peptic Ulcer Therapeutics Market Size (2005-2010) - Global 16 3.2 Peptic Ulcer Therapeutics Market Forecast (2010-2018) - Global 17 3.3 Peptic Ulcer Therapeutics Market Size (2005-2010) - The US 18 3.4 Peptic Ulcer Therapeutics Market Forecast (2010-2018) - The US 19 3.5 Peptic Ulcer Therapeutics Market Size (2005-2010) - France 20 3.6 Peptic Ulcer Therapeutics Market Forecast (2010-2018) - France 21 3.7 Peptic Ulcer Therapeutics Market Size (2005-2010) - Germany 22 3.8 Peptic Ulcer Therapeutics Market Forecast (2010–2018) - Germany 23 3.9 Peptic Ulcer Therapeutics Market Size (2005-2010) - Italy 24 3.10 Peptic Ulcer Therapeutics Market Forecast (2010–2018) - Italy 25 3.11 Peptic Ulcer Therapeutics Market Size (2005–2010) - Spain 26 3.12 Peptic Ulcer Therapeutics Market Forecast (2010-2018) - Spain 27 3.13 Peptic Ulcer Therapeutics Market Size (2005-2010) - The UK 28 3.14 Peptic Ulcer Therapeutics Market Forecast (2010–2018) - The UK 29 3.15 Peptic Ulcer Therapeutics Market Size (2005-2010) - Japan 30
Website : http://www.aarkstore.com/
AArkstore enterprise 3.16 Peptic Ulcer Therapeutics Market Forecast (2010–2018) - Japan 31 3.17 Drivers and Barriers for the Peptic Ulcer Therapeutics Market 32 3.17.1 Drivers for the Peptic Ulcer Therapeutics Market 32 3.17.2 Barriers for the Peptic Ulcer Therapeutics Market 32 3.18 Opportunity and Unmet Need Analysis 32 3.19 Key Takeaway 33 4 Peptic Ulcer Therapeutics - Competitive Assessment 34 4.1 Overview 34 4.2 Key Brands in the Peptic Ulcer Therapeutics Market 34 4.3 Strategic Competitor Assessment 35 4.4 Product Profiles for the Major Marketed Products in the Peptic Ulcer Therapeutics Market 35 4.4.1 Nexium (esomeprazole magnesium) 35 4.4.2 Vimovo (naproxen/esomeprazole magnesium) 38 4.4.3 Pariet/Aciphex (rabeprazole sodium) 39 4.5 Key Takeaway 40 5 Peptic Ulcer Therapeutics - Pipeline Assessment 41 5.1 Overview 41 5.2 Strategic Pipeline Assessment 41 5.3 Peptic Ulcer Therapeutics Pipeline - Pipeline by Phases of Development 41 5.3.1 Peptic Ulcer Therapeutics - Filed Pipeline 42 5.3.2 Peptic Ulcer Therapeutics - Phase III Pipeline 42 5.3.3 Peptic Ulcer Therapeutics - Phase II Pipeline 42 5.3.4 Peptic Ulcer Therapeutics - Pre-Clinical Pipeline 42
Website : http://www.aarkstore.com/
AArkstore enterprise 5.3.5 Technology Trends Analytic Framework 43 5.4 Peptic Ulcer Therapeutics Market - Clinical Pipeline by Mechanism of Action 45 5.5 Peptic Ulcer Therapeutics - Promising Drugs under Clinical Development 45 5.6 Molecule Profile for Promising Drugs under Clinical Development 46 5.6.1 Axanum 46 5.6.2 PA32540 46 5.7 Key Takeaway 47 6 Peptic Ulcer Therapeutics - Clinical Trials Mapping 48 6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 48 6.2 Clinical Trials by Phase 49 6.3 Clinical Trials by Trial Status 50 6.4 Prominent Sponsors 51 6.5 Top Companies Participating in Peptic Ulcer Therapeutics Clinical Trials 53 7 Strategic Assessment 54 7.1 Key Events Impacting the Future Market 54 7.2 Peptic Ulcer Therapeutics: Implications for Future Market Competition 55 8 Peptic Ulcer Therapeutics - Future Players 56 8.1 Introduction 56 8.2 Company Profiles 56 8.2.1 AstraZeneca 56 8.2.2 Pozen 58 8.2.3 Other Companies 60 9 Peptic Ulcer Therapeutics - Licensing and Partnership Deals 61
Website : http://www.aarkstore.com/
AArkstore enterprise 10 Peptic Ulcer Therapeutics - Appendix 63 10.1 Market Definitions 63 10.2 Abbreviations 63 10.3 Methodology 64 10.3.1 Coverage 64 10.3.2 Secondary Research 64 10.3.3 Forecasting 65 10.3.4 Primary Research 67 10.3.5 Expert Panel Validation 67 10.4 Contact Us 67 10.5 Disclaimer 67 10.6 Bibliography 68
List Of Tables Table 1: Peptic Ulcer Therapeutics Market, Global, Revenue ($m), 2005-2010 16 Table 2: Peptic Ulcer Therapeutics Market, Global, Forecasts ($m), 2010-2018 17 Table 3: Peptic Ulcer Therapeutics Market, The US, Revenue ($m), 2005-2010 18 Table 4: Peptic Ulcer Therapeutics Market, The US, Forecasts ($m), 2010-2018 19 Table 5: Peptic Ulcer Therapeutics Market, France, Revenue ($m), 2005-2010 20 Table 6: Peptic Ulcer Therapeutics Market, France, Forecasts ($m), 2010-2018 21 Table 7: Peptic Ulcer Therapeutics Market, Germany, Revenue ($m), 2005-2010 22
Website : http://www.aarkstore.com/
AArkstore enterprise Table 8: Peptic Ulcer Therapeutics Market, Germany, Forecasts ($m), 2010-2018 23 Table 9: Peptic Ulcer Therapeutics Market, Italy, Revenue ($m), 2005-2010 24 Table 10: Peptic Ulcer Therapeutics Market, Italy, Forecasts ($m), 2010-2018 25 Table 11: Peptic Ulcer Therapeutics Market, Spain, Revenue ($m), 2005-2010 26 Table 12: Peptic Ulcer Therapeutics Market, Spain, Forecasts ($m), 2010-2018 27 Table 13: Peptic Ulcer Therapeutics Market, The UK, Revenue ($m), 2005-2010 28 Table 14: Peptic Ulcer Therapeutics Market, The UK, Forecasts ($m), 2010-2018 29 Table 15: Peptic Ulcer Therapeutics Market, Japan, Revenue ($m), 2005-2010 30 Table 16: Peptic Ulcer Therapeutics Market, Japan, Forecasts ($m), 2010-2018 31 Table 17: Key Drugs in the Peptic Ulcer Therapeutics Market 34 Table 18: Efficacy of Nexium 36 Table 19: Clinical Studies of Nexium 37 Table 20: Efficacy of Vimovo 38 Table 21: Common Treatment Emergent Adverse Events Associated with Vimovo 38 Table 22: Clinical Studies of Vimovo 38 Table 23: Efficacy of Aciphex 39 Table 24: Clinical Studies of Aciphex 40 Table 25: Peptic Ulcer Therapeutics, Filed Pipeline, 2011 42 Table 26: Peptic Ulcer Therapeutics, Phase III Pipeline, 2011 42 Table 27: Peptic Ulcer Therapeutics, Phase II Pipeline, 2011 42 Table 28: Peptic Ulcer Therapeutics, Pre-Clinical Pipeline, 2011 42 Table 29: Peptic Ulcer Therapeutics, Most Promising Drugs under Clinical Development, 2011 45 Table 30: Peptic Ulcer Therapeutics, Clinical Trials by Country, 2011 48
Website : http://www.aarkstore.com/
AArkstore enterprise Table 31: Peptic Ulcer Therapeutics, Clinical Trials by Phase, 2011 49 Table 32: Peptic Ulcer Therapeutics, Clinical Trials by Status (%), 2011 50 Table 33: Peptic Ulcer Therapeutics, Prominent Sponsors, 2011 52 Table 34: Peptic Ulcer Therapeutics, Top Companies Participating in Clinical Trials, 2011 53 Table 35: AstraZeneca, Peptic Ulcer Pipeline, 2011 58 Table 36: Pozen, Peptic Ulcer Pipeline, 2011 59 Table 37: Peptic Ulcer Therapeutics Market, Future Players 60 Table 38: Peptic Ulcer Therapeutics, Global, Deals, 2009-2011 61
List Of Figures Figure 1: Peptic Ulcer Therapeutics, Types of Peptic Ulcer 7 Figure 2: Peptic Ulcer Therapeutics, Pathophysiology of NSAID-Induced Peptic Ulcer 10 Figure 3: Peptic Ulcer Therapeutics, Pathophysiology 11 Figure 4: Treatment Algorithm for NSAID-Induced Peptic Ulcer 14 Figure 5: Peptic Ulcer Therapeutics Market, Global, Revenue ($m), 2005-2010 16 Figure 6: Peptic Ulcer Therapeutics Market, Global, Forecast ($m), 2010-2018 17 Figure 7: Peptic Ulcer Therapeutics Market, The US, Revenue ($m), 2005-2010 18 Figure 8: Peptic Ulcer Therapeutics Market, The US, Forecast ($m), 2010-2018 19 Figure 9: Peptic Ulcer Therapeutics Market, France, Revenue ($m), 2005-2010 20 Figure 10: Peptic Ulcer Therapeutics Market, France, Forecast ($m), 2010-2018 21 Figure 11: Peptic Ulcer Therapeutics Market, Germany, Revenue ($m), 2005-2010 22 Figure 12: Peptic Ulcer Therapeutics Market, Germany, Forecast ($m), 2010-2018 23 Figure 13: Peptic Ulcer Therapeutics Market, Italy, Revenue ($m), 2005-2010 24
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 14: Peptic Ulcer Therapeutics Market, Italy, Forecast ($m), 2010-2018 25 Figure 15: Peptic Ulcer Therapeutics Market, Spain, Revenue ($m), 2005-2010 26 Figure 16: Peptic Ulcer Therapeutics Market, Spain, Forecast ($m), 2010-2018 27 Figure 17: Peptic Ulcer Therapeutics Market, The UK, Revenue ($m), 2005-2010 28 Figure 18: Peptic Ulcer Therapeutics Market, The UK, Forecast ($m), 2010-2018 29 Figure 19: Peptic Ulcer Therapeutics Market, Japan, Revenue ($m), 2005-2010 30 Figure 20: Peptic Ulcer Therapeutics Market, Japan, Forecast ($m), 2010-2018 31 Figure 21: Opportunity and Unmet Need in the Peptic Ulcer Therapeutics Market, 2010 33 Figure 22: Peptic Ulcer Therapeutics, Strategic Competitor Assessment, 2010 35 Figure 23: Peptic Ulcer Therapeutics, Pipeline by Phase of Development, 2011 41 Figure 24: Peptic Ulcer Therapeutics, Technology Trends Analytics Framework, 2011 43 Figure 25: Peptic Ulcer Therapeutics, Technology Trends Analytics Framework, Description, 2011 44 Figure 26: Peptic Ulcer Therapeutics, Pipeline by Mechanism of Action (%), 2011 45 Figure 27: Peptic Ulcer Therapeutics, Efficacy of PA32540 47 Figure 28: Peptic Ulcer Therapeutics, Clinical Trials by Country, 2011 48 Figure 29: Peptic Ulcer Therapeutics, Clinical Trials by Phase (%), 2011 49 Figure 30: Peptic Ulcer Therapeutics, Clinical Trials by Status (%), 2011 50 Figure 31: Peptic Ulcer Therapeutics, Overall Sponsors (%), 2011 51 Figure 32: Peptic Ulcer Therapeutics, Prominent Sponsors (%), 2011 52 Figure 33: Peptic Ulcer Therapeutics, Top Companies Participating in Clinical Trials, 2011 53 Figure 34: Peptic Ulcer Therapeutics Market, Drivers and Restraints, 2011 54 Figure 35: Implications for Future Market Competition in the Peptic Ulcer Market, 2011 55 Figure 36: Peptic Ulcer Therapeutics Market, Pipeline by Company, 2011 56
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 37: GlobalData Market Forecasting Model 66
Related reports: Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Diabetic Peripheral Neuropathy - Pipeline Review, H2 2014 Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014 Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H2 2014 Mycosis Fungoides - Pipeline Review, H2 2014 Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2014 Papillary Thyroid Cancer - Pipeline Review, H2 2014 Choroidal Neovascularization - Pipeline Review, H2 2014 Spasticity - Pipeline Review, H2 2014
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60326/peptic-ulcertherapeutics-pipeline-assessment-and-market-forecasts
Contact Details:
Website : http://www.aarkstore.com/
AArkstore enterprise Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/